Laser Photocoagulation and Ranibizumab Treatment in Proliferative Diabetic Retinopathy

by | Sep 18, 2026 | Clinical Trials | 0 comments

​ Conditions: Proliferative Diabetic Retinopathy (PDR)

Interventions: Drug: Ranibizumab 0.5 mg; Procedure: laser photocoagulation (PRP)

Sponsors: Aswan University

Completed Conditions: Proliferative Diabetic Retinopathy (PDR)
Interventions: Drug: Ranibizumab 0.5 mg; Procedure: laser photocoagulation (PRP)
Sponsors: Aswan University
Completed 

Submit a Comment

Your email address will not be published. Required fields are marked *